OXFORD GENETICS

oxford-genetics-logo

Oxford Genetics is a UK-based biotechnology company specializing in the production of versatile cloning plasmids for research in academic and biotechnology institutions. They also provide custom cloning and DNA synthesis. All of their products are free of intellectual property restrictions.

#People #Financial #Event #Website #More

OXFORD GENETICS

Social Links:

Industry:
Biotechnology Genetics

Founded:
2011-04-28

Address:
Upper Heyford, Somerset, United Kingdom

Country:
United Kingdom

Website Url:
http://www.oxgene.com

Total Employee:
51+

Status:
Active

Contact:
+44 18 6923 8004

Email Addresses:
socialmedia@oxgene.co.uk

Total Funding:
16.76 M GBP

Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS Cloudflare JS Microsoft Microsoft Azure Shutterstock Symantec Secure Site KnowBe4


Current Employees Featured

laura-ciccolini_image

Laura Ciccolini
Laura Ciccolini Head of Commercial Management @ Oxford Genetics
Head of Commercial Management
2022-01-01

ryan-cawood_image

Ryan Cawood
Ryan Cawood Chief Scientific Officer @ Oxford Genetics
Chief Scientific Officer
2021-03-01

leonard-seymour_image

Leonard Seymour
Leonard Seymour Founder @ Oxford Genetics
Founder

joan-gannon_image

Joan Gannon
Joan Gannon Solutions Manager @ Oxford Genetics
Solutions Manager
2019-09-01

Founder


leonard-seymour_image

Leonard Seymour

ryan-cawood_image

Ryan Cawood

Investors List

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Venture Round - Oxford Genetics

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Venture Round - Oxford Genetics

invesco-perpetual-2_image

Invesco Perpetual

Invesco Perpetual investment in Venture Round - Oxford Genetics

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Venture Round - Oxford Genetics

mercia-technologies_image

Mercia Asset Management PLC

Mercia Asset Management PLC investment in Grant - Oxford Genetics

innovate-u-k-_image

Innovate UK

Innovate UK investment in Grant - Oxford Genetics

mercia-fund-management_image

Mercia Fund Managers

Mercia Fund Managers investment in Venture Round - Oxford Genetics

mercia-fund-management_image

Mercia Fund Managers

Mercia Fund Managers investment in Seed Round - Oxford Genetics

Newest Events participated

cell-gene-therapy-bioprocessing-commercialization-2017_event_image Participated in Cell & Gene Therapy Bioprocessing & Commercialization 2017 on 2017-09-25 as exhibitor

viral-safety-2017_event_image Participated in Viral Safety 2017 on 2017-04-25 as sponsor

bioprocess-international-european-summit-2017_event_image Participated in BioProcess International European Summit 2017 on 2017-04-25 as sponsor

cell-line-development-engineering-2017_event_image Participated in Cell Line Development & Engineering 2017 on 2017-04-24 as sponsor

Official Site Inspections

http://www.oxgene.com

  • Host name: acd89244c803f7181.awsglobalaccelerator.com
  • IP address: 75.2.60.5
  • Location: Seattle United States
  • Latitude: 47.54
  • Longitude: -122.3032
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98108

Loading ...

More informations about "Oxford Genetics"

OXGENE | Lab Manager

Organization profile for OXGENE on Lab Manager. OXGENE OXGENE, a WuXi Advanced Therapies company, accelerates the delivery of gene therapy and biologics with its scalable …See details»

WuXi AppTec Completes Acquisition of OXGENE to Further …

Mar 1, 2021 PHILADELPHIA and OXFORD, March 2, 2021 - WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in the pharmaceutical, biotechnology …See details»

WuXi AppTec Completes Acquisition of OXGENE to Further

Mar 2, 2021 OXGENE will become a fully-owned subsidiary of WuXi Advanced Therapies (WuXi ATU), WuXi AppTec's cell and gene therapy Contract Testing, Development and …See details»

OXGENE Profile | The Scientist

May 10, 2021 Gilead’s Capsid Revolution Meets Our Capsid Solutions: Sino Biological – Engineering the Tools to Outsmart HIV. On February 18, 2025, Gilead Sciences announced a …See details»

OXGENE Overview | SignalHire Company Profile

Organization Website: oxgene.com : Phone Number +44 1865 415 107: OXGENE industries BiotechSee details»

OXGENE

WEIHENG SU, PH.D. HEAD OF AAV, OXGENE & WuXi ATU ... WuXi Advanced Therapies is a global Contract Testing, Development and Manufacturing Organization (CTDMO) …See details»

OXGENE - Org Chart, Teams, Culture & Jobs | The Org

View OXGENE's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»

OXGENE (Oxford Genetics) - VentureRadar

May 1, 2020 OXGENE find solutions to seemingly impossible problems. We develop new technologies in mammalian cell engineering along the whole spectrum from discovery science …See details»

OXGENE Company Profile - Office Locations, Competitors, …

OXGENE has 5 employees across 2 locations and £1.01 m in annual revenue in FY 2018. See insights on OXGENE including office locations, competitors, revenue, financials, executives, …See details»

Oxford Genetics Company Information - Funding, Investors, and …

Key Insights: Oxford Genetics funding round, March 28, 2019: $8m Oxford Genetics seed round: $227.29k Oxford Genetics Venture round, July 2015: $698.74k Oxford Genetics Grant …See details»

OXGENE - 2025 Company Profile - Tracxn

Mar 1, 2025 OXGENE. has raised a total funding of $27.1M over 12 rounds. Its first funding round was on Jun 01, 2011. What are the most recent funding rounds of OXGENE? Its latest …See details»

WuXi AppTec Completes Acquisition of OXGENE | Pharmaceutical ...

Mar 3, 2021 WuXi AppTec has completed the acquisition of OXGENE, a United Kingdom-based contract research and development organization that designs and develops scalable gene …See details»

Oxgene | Oxford - Facebook

Oxgene, Oxford, Oxfordshire. 1,600 likes · 56 were here. OXGENE redefines possible in mammalian cell engineering. Our technology platforms and expert solutioSee details»

Oxford Genetics - Crunchbase Company Profile & Funding

OXGENE has developed TESSA technology to simplify the manufacturing of adeno-associated viral vectors, enhancing scalability and reducing costs. LentiVEX Plasmids and Cell Lines: …See details»

OXGENE - Products, Competitors, Financials, Employees, …

About OXGENE. OXGENE's technology platforms and solutions accelerate the discovery, development, and manufacture of cell and gene therapies. The firm provides high-titer viral …See details»

Plasmid Manufacture - OXGENE

OXGENE’s plasmid engineering expertise, combined with WuXi Advanced Therapies’ robust manufacturing processes, together provide a streamlined workflow for rapid production and …See details»

Oxgene Company Profile Funding & Investors | YourStory

OXGENE, a WuXi Advanced Therapies (WuXi ATU) company, based in Oxford, UK, provides cell and gene therapy pioneers around the world with the technologies, automation platforms and …See details»

OXGENE - The Oxford Magazine

Apr 2, 2020 Two Oxford businesses – OXGENE™ and The Native Antigen Company – have formed a strategic partnership to scale-up SARS-CoV-2 (COVID-19) antigen production. 02 …See details»

A solution to the Viral Production Bottleneck for Cell and Gene …

OXGENE is a trading name of Oxford Genetics LTD. Registered in England & Wales. Company No. 07617346. Registered office: Medawar Centre, Robert Robinson Avenue, Oxford, OX4 4HG.See details»

Advanced Therapies Discovery Services from OXGENE

OXGENE’s SnapFast™ plasmids are versatile and efficient. These modular plasmids are designed to work like ‘molecular building blocks’, using a catalogue of well characterized DNA …See details»